Literature DB >> 18199944

Behavioral therapies for overactive bladder: making sense of the evidence.

Jill L Milne1.   

Abstract

Overactive bladder (OAB) is a symptom-based syndrome characterized by the presence of urgency, which is defined as a sudden and compelling desire to void that cannot be postponed. OAB may significantly impact of quality of life. Numerous treatment options exist for OAB, including behavioral therapies such as pelvic floor muscle rehabilitation, bladder training, and dietary modification, as well as traditional therapies such as pharmacological therapy and neuromodulation. Behavioral therapies are considered the mainstay of treatment for urinary incontinence in general. However the efficacy of these noninvasive strategies for OAB treatment has not been well addressed in the literature. This article presents an overview of current evidence with attention to the clinical relevance of findings related to lifestyle modification, bladder training, and pelvic floor muscle training. Initial evidence suggests that obesity, smoking, and consumption of carbonated drinks are risk factors for OAB but there is less support for the contributory role of caffeine or the impact of caffeine reduction. The evidence supporting bladder training and pelvic floor muscle training is more consistent and a trend towards combining these therapies to treat OAB appears positive. Given the prevalence of OAB and growing support for the efficacy of behavioral treatments it is important and timely to augment existing evidence with well-designed multicenter trials.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18199944     DOI: 10.1097/01.WON.0000308624.68582.19

Source DB:  PubMed          Journal:  J Wound Ostomy Continence Nurs        ISSN: 1071-5754            Impact factor:   1.741


  14 in total

1.  Fluid manipulation among individuals with lower urinary tract symptoms: a mixed methods study.

Authors:  Emily A Elstad; Nancy N Maserejian; John B McKinlay; Sharon L Tennstedt
Journal:  J Clin Nurs       Date:  2010-11-15       Impact factor: 3.036

2.  Behavioral intervention versus pharmacotherapy or their combinations in the management of overactive bladder dysfunction.

Authors:  Khanh Tran; Robert M Levin; Shaker A Mousa
Journal:  Adv Urol       Date:  2009-12-15

3.  CUA guideline on adult overactive bladder.

Authors:  Jacques Corcos; Mikolaj Przydacz; Lysanne Campeau; Gary Gray; Duane Hickling; Christiane Honeine; Sidney B Radomski; Lynn Stothers; Adrian Wagg; Frcp Lond
Journal:  Can Urol Assoc J       Date:  2017-05-09       Impact factor: 1.862

4.  Moderating perceptions of bother reports by individuals experiencing lower urinary tract symptoms.

Authors:  Elizabeth M Botelho; Emily A Elstad; Simone P Taubenberger; Sharon L Tennstedt
Journal:  Qual Health Res       Date:  2011-04-11

5.  The effects of drug and behavior therapy on urgency and voiding frequency.

Authors:  Kathryn L Burgio; Stephen R Kraus; Diane Borello-France; Toby C Chai; Kimberly Kenton; Patricia S Goode; Yan Xu; John W Kusek
Journal:  Int Urogynecol J       Date:  2010-02-09       Impact factor: 2.894

6.  Does conservative management really benefit patients with OAB?

Authors:  Philip E V Van Kerrebroeck
Journal:  Curr Urol Rep       Date:  2012-10       Impact factor: 3.092

7.  Contribution of behavioral and cognitive therapy to managing overactive bladder syndrome in women in the absence of contributive urodynamic diagnosis.

Authors:  Brigitte G Marti; Françoise A Valentini; Gilberte Robain
Journal:  Int Urogynecol J       Date:  2014-11-07       Impact factor: 2.894

8.  The association of adiposity and overactive bladder appears to differ by gender: results from the Boston Area Community Health survey.

Authors:  Carol L Link; William D Steers; John W Kusek; John B McKinlay
Journal:  J Urol       Date:  2011-01-19       Impact factor: 7.450

Review 9.  Practical aspects of lifestyle modifications and behavioural interventions in the treatment of overactive bladder and urgency urinary incontinence.

Authors:  J F Wyman; K L Burgio; D K Newman
Journal:  Int J Clin Pract       Date:  2009-07-02       Impact factor: 2.503

10.  Overactive bladder, differential diagnosis, and clinical utility of fesoterodine.

Authors:  Jean-Jacques Wyndaele
Journal:  Int J Gen Med       Date:  2012-11-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.